Company / Gross Margin
BeOne Medicines Ltd. Gross Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
87.5%
FY2025
5-year range
79.8% / 87.5%
FY2021-FY2025
Trend
+3.6%
vs FY2024
Sector context
#5 of 28
Health Care
What the data says
BeOne Medicines Ltd.'s gross margin of 87.5% is higher than 82% of companies in the Health Care sector (FY2025). Gross Margin remained relatively stable over the past 5 years, with values between 79.8% and 87.5%.
Based on SEC 10-K filings.
87.5% in FY2025 with a 3-year CAGR of +7.7%. Top quartile in the Health Care sector.
Improved from 84.5% to 87.5% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +7.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 18% in Health CareTop 18% of 28This company 87.5% Sector average 60.3%
▼
+45.1% above sector average
Key checks
Key Insights
- In FY2025, gross margin increased 3.6% year-over-year.
- Currently 27.2pp above the Health Care sector average.
- Lowest gross margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 87.5% | +3.6% |
| FY2024 | 84.4% | -0.2% |
| FY2023 | 84.5% | +6.0% |
| FY2022 | 79.8% | -7.2% |
| FY2021 | 86.0% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026